$718.20
-3.43-0.48%
Last update: Nov 10, 4:00 PM
Thermo Fisher Scientific Inc
TMONYSE
Thermo Fisher Scientific rose 25.2% from $576.35 to a 1-year high of $721.63, ahead of the S&P 500's +10.0%. Its worst day was Apr 23 (−9.2%), and its low came May 15 at $438.34.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $6.57 beat the $6.44 estimate on $12.2B revenue (est. $11.9B); FY revenue guidance of $46.3B–$47.2B against the $46.5B consensus.
−2.6% · S&P 500 −0.2%
Story events cover the past 12 months · Times ET
EPS of $5.44 beat the $5.23 estimate on $11.0B revenue (est. $10.9B); FY revenue guidance of $47.3B–$48.1B against the $47.5B consensus.
−9.2%, the year's worst day · S&P 500 −0.4%
Thermo Fisher Scientific closed at its lowest level of the year, 23.9% below where the year started.
−2.2% · S&P 500 −1.2%
Thermo Fisher Scientific shares rose 6.8%, while the S&P 500 rose 0.6%.
+6.8% · S&P 500 +0.6%
Thermo Fisher Scientific shares rose 5.2%, while the S&P 500 fell 0.3%.
+5.2% · S&P 500 −0.3%
Thermo Fisher Scientific shares rose 4.9%, while the S&P 500 fell 0.0%.
+4.9% · S&P 500 0.0%
EPS of $6.03 beat the $5.71 estimate on $12.0B revenue (est. $11.7B); FY revenue guidance of $47.4B–$48.1B against the $47.8B consensus.
+8.7%, the year's best day, on 6M shares, the year's heaviest volume · S&P 500 −1.2%
EPS of $6.68 beat the $6.40 estimate on $12.1B revenue (est. $11.9B); FY revenue guidance of $47.7B–$48.2B against the $47.9B consensus.
+1.0% · S&P 500 +0.5%
Where it ended: a 1-year high close of $721.63 on Nov 9, 2026. Up next: Q4 2026 earnings on Jan 28, 2027 (EPS est. $7.13, revenue est. $12.9B).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TMO and SPY from Benzinga historical bars. Not investment advice.
